Versant Side Fund Iv, L.p. - Net Worth and Insider Trading

Versant Side Fund Iv, L.p. Net Worth

The estimated net worth of Versant Side Fund Iv, L.p. is at least $224 Million dollars as of 2024-05-05. Versant Side Fund Iv, L.p. is the 10% Owner of CRISPR Therapeutics AG and owns about 4,004,248 shares of CRISPR Therapeutics AG (CRSP) stock worth over $224 Million. Details can be seen in Versant Side Fund Iv, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Versant Side Fund Iv, L.p. has not made any transactions after 2018-04-23 and currently still holds the listed stock(s).

Transaction Summary of Versant Side Fund Iv, L.p.

To

Versant Side Fund Iv, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Versant Side Fund Iv, L.p. owns 7 companies in total, including IVERIC bio Inc (ISEE) , Inari Medical Inc (NARI) , and Oyster Point Pharma Inc (OYST) among others .

Click here to see the complete history of Versant Side Fund Iv, L.p.’s form 4 insider trades.

Insider Ownership Summary of Versant Side Fund Iv, L.p.

Ticker Comapny Transaction Date Type of Owner
ISEE IVERIC bio Inc 2018-10-30 10 percent owner
NARI Inari Medical Inc 2020-11-17 10 percent owner
OYST Oyster Point Pharma Inc 2019-10-30 10 percent owner
2018-04-23 10 percent owner
2016-07-19 10 percent owner
2011-11-15 10 percent owner
2022-04-29 10 percent owner

Versant Side Fund Iv, L.p. Latest Holdings Summary

Versant Side Fund Iv, L.p. currently owns a total of 1 stock. Versant Side Fund Iv, L.p. owns 4,004,248 shares of CRISPR Therapeutics AG (CRSP) as of April 23, 2018, with a value of $224 Million.

Latest Holdings of Versant Side Fund Iv, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CRSP CRISPR Therapeutics AG 2018-04-23 4,004,248 55.89 223,797,421

Holding Weightings of Versant Side Fund Iv, L.p.


Versant Side Fund Iv, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Versant Side Fund Iv, L.p. has made a total of 0 transactions in CRISPR Therapeutics AG (CRSP) over the past 5 years. The most-recent trade in CRISPR Therapeutics AG is the sale of 101,994 shares on April 23, 2018, which brought Versant Side Fund Iv, L.p. around $5 Million.

Insider Trading History of Versant Side Fund Iv, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Versant Side Fund Iv, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Versant Side Fund Iv, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Versant Side Fund Iv, L.p. is 35.26%. GuruFocus also compares Versant Side Fund Iv, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Versant Side Fund Iv, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Versant Side Fund Iv, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Versant Side Fund Iv, L.p.

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 38.04
Relative Return to S&P 500(%) 35.56

Versant Side Fund Iv, L.p. Ownership Network

Ownership Network List of Versant Side Fund Iv, L.p.

No Data

Ownership Network Relation of Versant Side Fund Iv, L.p.


Versant Side Fund Iv, L.p. Owned Company Details

What does IVERIC bio Inc do?

Who are the key executives at IVERIC bio Inc?

Versant Side Fund Iv, L.p. is the 10 percent owner of IVERIC bio Inc. Other key executives at IVERIC bio Inc include SVP & COO Keith Westby , SVP & CFO and Treasurer David Francis Carroll , and Senior Vice President & CCO Christopher Paul Simms .

IVERIC bio Inc (ISEE) Insider Trades Summary

Over the past 18 months, Versant Side Fund Iv, L.p. made no insider transaction in IVERIC bio Inc (ISEE). Other recent insider transactions involving IVERIC bio Inc (ISEE) include a net sale of 243,904 shares made by Keith Westby , a net sale of 128,049 shares made by David Francis Carroll , and a net sale of 19,457 shares made by Glenn Sblendorio .

In summary, during the past 3 months, insiders sold 0 shares of IVERIC bio Inc (ISEE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 391,410 shares of IVERIC bio Inc (ISEE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 391,410 shares.

IVERIC bio Inc (ISEE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

IVERIC bio Inc Insider Transactions

No Available Data

Versant Side Fund Iv, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Versant Side Fund Iv, L.p.. You might contact Versant Side Fund Iv, L.p. via mailing address: One Sansome Street, Suite 3630, San Francisco Ca 94104.

Discussions on Versant Side Fund Iv, L.p.

No discussions yet.